The impact of complementary and alternative treatment modalities on the care of orthopaedic patients

Journal of the American Academy of Orthopaedic Surgeons

Volumn 19, Issue 10, 2011, Pages 634-643

  Rispler, David T ^a   Sara, Julie ^a  

^a Michigan Orthopedic Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80054809949     PISSN: 1067151X     EISSN: None     Source Type: Journal    
DOI: 10.5435/00124635-201110000-00007     Document Type: Review

References (51)

1. Eisenberg DM, Davis RB, Ettner SL,et al: Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA 1998;280(18):1569-1575.
2. Tindle HA, Davis RB, Phillips RS,Eisenberg DM: Trends in use of complementary and alternative medicine by US adults: 1997-2002. Ahem Ther Health Med 2005;11(1):42-49. (Pubitemid 40110627)
3. Cohen RJ, Ek K, Pan CX: Complementary and alternative medicine (CAM) use by older adults: A comparison of self-report and physician chart documentation. Gerontol A Biol Sci Med Sci 2002;57(4):M223-M227. (Pubitemid 34263299)
4. Rosenberg EI, Genao I, Chen I, et al: Complementary and alternative medicine use by primary care patients with chronic pain. Pain Med 2008;9(8):1065-1072.
5. Norred CL: Complementary and alternative medicine use by surgical patients. AORN J 2002;76(6):1013-1021.
6. Wren KR, Kimbrall S, Norred CL: Use of complementary and alternative medications by surgical patients./ Perianesth Nurs 2002;17(3):170-177. (Pubitemid 40433766)
7. Marsh J, Hager C, Havey T, Sprague S, Bhandari M, Bryant D: Use of alternative medicines by patients with OA that adversely interact with commonly prescribed medications. Clin Orthop Relat Res 2009;467(10):2705-2722.
8. Rispler D, Sara J, Davenport L, Mills B, Iskra C: Underreporting of complementary and alternative medicine use among arthritis patients in an orthopedic clinic. Am J Orthop (Belle Mead NJ) 2011;40(5):E92-E95.
9. Nahin RL, Barnes PM, Stussman BJ, Bloom B: Costs of complementary and alternative medicine(CAM) and frequency of visits to CAM practitioners: United States, 2007. Natl Health Stat Report 2009;(18):1-14.
10. Lim A, Cranswick N, South M: Adverse events associated with the use of complementary and alternative medicine in children. Arch Dis Child 2011;96(3): 297-300.
11. Blendon RJ, DesRoches CM, Benson JM, Brodie M, Altman DE: Americans' views on the use andregulation of dietary supplements. Arch Intern Med 2001; 161(6):805-810. (Pubitemid 32225388)
12. Howe CR, Gardner GC, Kadel NJ: Perioperative medication management for the patient with rheumatoid arthritis. J Am Acad Orthop Surg 2006;14(9):544-551. (Pubitemid 44916630)
13. Trapskin P, Smith KM: Herbal medications in the perioperative orthopedic surgery patient. Orthopedics 2004;27(8):819-822. (Pubitemid 39173370)
14. Cavaliere C, Rea P, Lynch M, Blumenthal M: Herbal supplement sales experience slight increase in 2008. Herbal Gram 2009;82:58-61.
15. Cavaliere C, Rea P, Lynch M,Blumenthal M: Herbal supplement sales rise in all channels in 2009. Herbal Gram 2010;86:62-65.
16. Ko R: Adverse reactions to watch for in patients using herbal remedies. West ] AW 1999;171(3):18M86.
17. O'Hara M, Kiefer D, Farrell K, Kemper K: A review of 12 commonly used medicinal herbs. Arch Fam Med 1998; 7(6):523-536. (Pubitemid 128433264)
18. Izzo AA, Ernst E: Interactions between herbal medicines and prescribed drugs: An updated systematic review. Drugs 2009;69(13):1777-1798.
19. Abebe W: Herbal medication: Potential for adverse interactions with analgesic drugs.; Clin Pharm Ther 2002;27(6): 391-401. (Pubitemid 35469171)
20. Brazier NC, Levine MA: Drug-herb interaction among commonly used conventional medicines: A compendium for health care professionals. Am J Ther 2003;10(3):163-169.
21. Guay DR: Cranberry and urinary tract infections. Drugs 2009;69(7):775-807.
22. Ansell J, McDonough M, Zhao Y, Harmatz JS, Greenblatt DJ: The absence of an interaction between warfarin and cranberry juice: A randomized, doubleblind trial./ Clin Pharmacol 2009;49(7): 824-830.
23. See DM, Broumand N, Sahl L, Tilles JG: In vitro effects of echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients. Immunopharmacology 1997;35(3):229-235. (Pubitemid 27063822)
24. Pittler MH, Ernst E: Kava extract for treating anxiety. Cochrane Database Syst Rei/2002;2:CD003383.
25. Reinhart KM, Talati R, White CM, Coleman CI: The impact of garlic onlipid parameters: A systematic review and meta-analysis. Nutr Res Rev 2009; 22(1):39-48.
26. Ang-Lee MK, Moss J, Yuan CS: Herbal medicines and perioperative care. JAMA 2001;286(2):208-216. (Pubitemid 32640852)
27. Park HJ, Lee JH, Song YB, Park KH: Effects of dietary supplementation of lipophilic fraction from Panax ginseng on cGMP and cAMP in rat platelets and on blood coagulation. Biol Pharm Bull 1996;19(11):1434-1439.
28. Janetzky K, Morreale AP: Probable interaction between warfarin and ginseng. Am J Health Syst Pharm 1997; 54(6):692-693. (Pubitemid 27136670)
29. Rambaldi A, Jacobs BP, Gluud C: Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases. Cochrane Database Syst Rev 2007;4:CD003620.
30. Suzuki M, Ito Y, Fujino T, et al: Pharmacological effects of saw palmetto extract in the lower urinary tract. Acta Pharmacol Sin 2009;30(3):227-281.
31. Tacklind J, MacDonald R, Rutks I, Wilt TJ: Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev2009;2:CD001423.
32. Blachier F, Lancha AH Jr, Boutry C, Tome D: Alimentary proteins, amino acids and cholesterolemia. Amino Acids 2010;38(1):15-22.
33. Linde K, Berner MM, Kriston L: St John's wort for major depression. Cochrane Database Syst Rev 2008;4: CD000448.
34. Taibi DM, Landis CA, Petry H, Vitiello MV: A systematic review of valerian as a sleep aid: Safe but not effective. Sleep Med Rev 2007;11(3):209-230. (Pubitemid 46756375)
35. Berger RG: Nonsteroidal antiinflammatory drugs: Making the right choices. / Am Acad Orthop Surg 1994; 2(5):255-260.
36. Clegg DO, Reda DJ, Harris CL, et al: Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 2006; 354(8):795-808. (Pubitemid 43290918)
37. Sawitzke AD, Shi H, Finco MF, et al: The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: A report from the glucosamine/chondroitin arthritis intervention trial. Arthritis Rheum 2008; 58(10):3183-3191.
38. Knudsen JF, Sokol GH: Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: Case report and review of the literature and MedWatch database. Pharmacotherapy 2008;28(4): 540-548. (Pubitemid 351466466)
39. Rutjes AW, Niiesch E, Reichenbach S, Jiini P: S-adenosylmethionine for osteoarthritis of the knee or hip. Cochrane Database Syst Rev 2009;4: CD007321.
40. Ameye LG, Chee WS: Osteoarthritis and nutrition: From nutraceuticals to functional foods. A systematic review of the scientific evidence. Arthritis Res Ther 2006;8(4):R127.
41. Yang CL, Chik SC, Li JC, Cheung BK, Lau AS: Identification of the bioactive constituent and its mechanisms of action in mediating the anti-inflammatory effects of black cohosh and related Cimicifuga species on human primary blood macrophages./ Med Chem 2009; 52(21):6707-6715.
42. Teschke R, Schwarzenboeck A, Hennermann KH: Kava hepatotoxicity: A clinical survey and critical analysis of 26 suspected cases. Eur J Gastroenterol Hepatol 2008;20(12):1182-1193.
43. Ernst E: Frankincense: Systematic review. Bivl/2008;337:a2813.
44. Kumakura S, Yamashita M, Tsurufuji S: Effect of bromelain on kaolin-induced inflammation in rats. Eur J Pharmacol 1988;150(3):295-301.
45. Brien S, Lewith G, Walker AF, Middleton R, Prescott P, Bundy R: Bromelain as an adjunctive treatment for moderate-to-severe osteoarthritis of the knee: A ra domized placebo-controlled pilot study. QJM 2006;99(12):841-850. (Pubitemid 46024095)
46. Rosenbaum CC, O'Mathiina DP, Chavez M, Shields K: Antioxidants and antiinflammatory dietary supplements for osteoarthritis and rheumatoid arthritis. Altem Ther Health Med 2010; 16(2):32-40.
47. Altavilla D, Squadrito F, Bitto A, et al: Flavocoxid, a dual inhibitor of cyclooxygenase and 5-lipoxygenase, blunts pro-inflammatory phenotype activation in endotoxin-stimulated macrophages. Br J Pharmacol 2009; 157(8):1410-1418.
48. Levy RM, Saikovsky R, Shmidt E, Khokhlov A, Burnett BP: Flavocoxid is as effective as naproxen for managing the signs and symptoms of osteoarthritis of the knee in humans: A short-term randomized, double-blind pilot study. NutrRes 2009;29(5):298-304.
49. Canter PH, Lee HS, Ernst E: A systematic review of randomised clinical trials of Tripterygium wilfordii for rheumatoid arthritis. Phytomedicine 2006;13(5):371-377. (Pubitemid 44382443)
50. Gregory PJ, Sperry M, Wilson AF: Dietary supplements for osteoarthritis. Am Earn Physician 2008;77(2):177-184 (Pubitemid 351162302)
51. Sun DX, Fang ZZ, Zhang YY, Cao YF, Yang L, Yin J: Inhibitory effects of curcumenol on human liver cytochrome P450 enzymes. Phytother Res 2010; 24(8):1213-1216